Published in Gene Therapy Weekly, March 18th, 2004
In a recent study, C.A. Kahl and colleagueas at Indiana University found that "envelope glycoproteins derived from both viruses can pseudotype human immunodeficiency virus type 1 (HIV-1)-derived lentivirus vectors."
"Both RRV and SFV glycoproteins considerably expand the host range of the lentivirus vector, and vectors can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.